[go: up one dir, main page]

JP2019193620A - OPH activity enhancer - Google Patents

OPH activity enhancer Download PDF

Info

Publication number
JP2019193620A
JP2019193620A JP2019029691A JP2019029691A JP2019193620A JP 2019193620 A JP2019193620 A JP 2019193620A JP 2019029691 A JP2019029691 A JP 2019029691A JP 2019029691 A JP2019029691 A JP 2019029691A JP 2019193620 A JP2019193620 A JP 2019193620A
Authority
JP
Japan
Prior art keywords
oph
activity
oph activity
enhancing
activity enhancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019029691A
Other languages
Japanese (ja)
Inventor
雅之 八木
Masayuki Yagi
雅之 八木
香 石崎
Kaori Ishizaki
香 石崎
和利 篠田
Kazutoshi Shinoda
和利 篠田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANTI AGING COMMUNICATION KK
HIKAWA KK
Original Assignee
ANTI AGING COMMUNICATION KK
HIKAWA KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANTI AGING COMMUNICATION KK, HIKAWA KK filed Critical ANTI AGING COMMUNICATION KK
Publication of JP2019193620A publication Critical patent/JP2019193620A/en
Priority to JP2023016664A priority Critical patent/JP2023052956A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

To provide, as enhancing the activity of OPH (oxidized proteolytic enzyme) in the living body may promote the degradation of oxidized proteins and glycated proteins, so-called aging proteins, and may prevent and treat aging and disease, and therefore an OPH activity enhancer that enhances the activity of OPH.SOLUTION: In order to solve the above-mentioned problems, an OPH activity enhancer containing at least any one of an extract of Yukinoshita (Saxifraga stolonifera ), Ume (Plum), Toki (Anjelica), Unshumikan (Cirtus unshiu), Mandarin orange, Hirami lemon, Tachibana (Citrus tachibana), Kawaraketsumei (Cassia nomame), Tougeshiba (Huperzia serrata), Rakanka (Momordicae grosvenori) as an active ingredient is provided. Also provided are foods, food additives, pharmaceuticals, quasi-drugs, cosmetics, etc. for enhancing OPH activity characterized by containing said OPH activity enhancer.SELECTED DRAWING: Figure 1

Description

本発明は、酸化蛋白質を分解する生体内酵素である酸化蛋白質分解酵素(oxidized protein hydrolase:OPH)の活性を増強させるOPH活性増強剤、及び、当該OPH活性増強剤を含有する飲食品や医薬品などに関する。   The present invention relates to an OPH activity enhancer that enhances the activity of oxidized protein hydrolase (OPH), which is an in vivo enzyme that degrades oxidized protein, and foods and beverages and pharmaceuticals containing the OPH activity enhancer. About.

OPHは、蛋白のN末端アシル化アミノ酸を遊離するセリンプロテアーゼの一種で、アシルアミノ酸遊離酵素(acylamino−Acid Releasing Enzyme:AARE)、アシル化ペプチド分解酵素(acylpeptide hydrolase:APH)などとも言われている。また、OPHは、アシル化だけでなく、ホルミル化(Formyl)、アセチル化(Acetyl)、ブチル化(Butyl)、プロピル化(Propyl)された蛋白質のN末端アミノ酸に対しても作用する。   OPH is a kind of serine protease that liberates N-terminal acylated amino acids of proteins, and is also referred to as acyl amino acid releasing enzyme (AARE), acylated peptide degrading enzyme (APH) and the like. . Further, OPH acts not only on acylation but also on the N-terminal amino acid of a protein that has been formylated (Formyl), acetylated (Acetyl), butylated (Butyl), or propylated (Propyl).

OPHはブタ肝臓、ラット脳、ヒト血液、角層などの生体組織に広く存在している。OPHは酸化蛋白質や糖化蛋白質を優先的に分解するとともにプロテアソームと協働して老化蛋白質を分解すること、アルツハイマー病の原因であるアミロイドβ蛋白質を減少させることが報告されている。またOPHがAGEs(終末糖化産物)を分解することも確認されている。これらのことから生体中のOPHの活性を増強させることは、老化蛋白質の分解を促進し、老化や疾患を予防・治療できる可能性がある(特許文献1)。   OPH is widely present in living tissues such as pig liver, rat brain, human blood, and stratum corneum. It has been reported that OPH preferentially degrades oxidized proteins and glycated proteins, degrades aging proteins in cooperation with the proteasome, and reduces amyloid β protein that causes Alzheimer's disease. It has also been confirmed that OPH degrades AGEs (terminal glycation products). From these facts, enhancing the activity of OPH in the living body promotes the degradation of aging proteins, and may possibly prevent or treat aging and diseases (Patent Document 1).

また、OPHには血中の有機リン系農薬の分解作用(非特許文献1)や、前立腺がんの抑制作用(非特許文献2)、眼レンズ水晶体物質であるクリスタリンの重合抑制作用(非特許文献3)、骨髄腫の抑制作用(非特許文献4)、農薬(クロルフィリホス)による細胞死の抑制(非特許文献5)などがあることも報告されている。   In addition, OPH has an action of decomposing organophosphorus pesticides in blood (Non-Patent Document 1), an effect of suppressing prostate cancer (Non-Patent Document 2), and an inhibitory action of crystallin, which is an eye lens lens substance (Non-Patent Document 1) Reference 3), myeloma inhibitory action (Non-patent document 4), suppression of cell death by pesticide (chlorphyrifos) (Non-patent document 5), and the like have also been reported.

国際公開番号WO2011/004733International Publication Number WO2011 / 004733

Gary B. Quistad, Rebecka Klintenberg, and John E. Casida, Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants. TOXICOLOGICAL SCIENCES 86(2), 291-299 (2005)Gary B. Quistad, Rebecka Klintenberg, and John E. Casida, Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants.TOXICOLOGICAL SCIENCES 86 (2), 291-299 (2005) Christopher A McGoldrick1, Yu-Lin Jiang, Victor Paromov, Marianne Brannon, Koyamangalath Krishnan and William L Stone, Identification of oxidized protein hydrolase as apotential prodrug target in prostate cancer. http://www.biomedcentral.com/1471-2407/14/77Christopher A McGoldrick1, Yu-Lin Jiang, Victor Paromov, Marianne Brannon, Koyamangalath Krishnan and William L Stone, Identification of oxidized protein hydrolase as apotential prodrug target in prostate cancer.http: //www.biomedcentral.com/1471-2407/14 / 77 R. Senthilkumar, P. Neelakanta Reddy AND K. Krishna Sharma, Studies on trypsin-modified bovine and human lens acylpeptide hydrolase. Exp. Eye Res. (2001) 72, 301±310R. Senthilkumar, P. Neelakanta Reddy AND K. Krishna Sharma, Studies on trypsin-modified bovine and human lens acylpeptide hydrolase. Exp. Eye Res. (2001) 72, 301 ± 310 Rosanna Palumbo, Marta Gogliettino , Ennio Cocca, Roberta Iannitti, Annamaria Sandomenico, Menotti Ruvo, Marco Balestrieri, Mose Rossi and Gianna Palmieri, APEH inhibition affects osteosarcoma cell viability via downregulation of the proteasome. Int. J. Mol. Sci. 2016, 17, 1614Rosanna Palumbo, Marta Gogliettino, Ennio Cocca, Roberta Iannitti, Annamaria Sandomenico, Menotti Ruvo, Marco Balestrieri, Mose Rossi and Gianna Palmieri, APEH inhibition affects osteosarcoma cell viability via downregulation of the proteasome.Int.J. Mol. Sci. 2016, 17 , 1614 Diana Cardona, Caridad Lopez-Granero, Fernando Canadas, Jordi Llorens, Pilar Flores, Floria Pancetti and Fernando Sanchez-Santed, Does-dependent regional brain acetylcholinesterase and acylpeptide hydrolase inhibition without cell death after chlorpyrifos administration. The Journal of Toxicological Sciences Vol.38, No.2, 193-203, 2013The Journal of Toxicological Sciences Vol. 38 , No.2, 193-203, 2013

上記の事情を鑑み、本発明は、OPHの活性を増強させるOPH活性増強剤を提供することを課題とする。   In view of the above circumstances, an object of the present invention is to provide an OPH activity enhancer that enhances the activity of OPH.

上記課題を解決するための手段として、以下の発明などを提供する。すなわち、ユキノシタ、ウメ、トウキ、カワラケツメイ、ウンシュウミカン、マンダリンオレンジ、ヒラミレモン、タチバナ、トウゲシバ、ラカンカのいずれか一種類以上を有効成分として含有するOPH活性増強剤を提供する。   As means for solving the above problems, the following inventions and the like are provided. That is, the present invention provides an OPH activity enhancer containing any one or more of Yukinoshita, Ume, Touki, Kawaraketsumei, Unshimikan, Mandarin Orange, Hiramemon, Tachibana, Togeshiba and Rakanka as an active ingredient.

また、前記いずれか一のOPH活性増強剤を含有することを特徴とする、OPH活性増強用食品、OPH活性増強用食品添加物、OPH活性増強用医薬品、OPH活性増強用医薬部外品及びOPH活性増強用化粧品を提供する。   Further, an OPH activity enhancing food, an OPH activity enhancing food additive, an OPH activity enhancing pharmaceutical, an OPH activity enhancing quasi-drug, and an OPH, comprising any one of the above OPH activity enhancing agents Provide cosmetics for enhancing activity.

本発明により、酸化蛋白質を分解する生体内酵素であるOPHの活性を増強させるOPH活性増強剤などを提供することができる。   The present invention can provide an OPH activity enhancer that enhances the activity of OPH, which is an in vivo enzyme that degrades oxidized protein.

各試料のOPH活性増強作用を示す表Table showing OPH activity enhancing effect of each sample

以下、本発明の実施例について説明する。なお、本発明は、これらの実施例に何ら限定されるべきものではなく、その要旨を逸脱しない範囲において、種々なる態様で実施し得る。
<実施形態>
<構成>
Examples of the present invention will be described below. In addition, this invention should not be limited at all to these Examples, and can be implemented with various aspects in the range which does not deviate from the summary.
<Embodiment>
<Configuration>

本実施例に係るOPH活性増強剤は、ユキノシタ、ウメ、トウキ、カワラケツメイ、ウンシュウミカン、マンダリンオレンジ、ヒラミレモン、タチバナ、トウゲシバ、ラカンカの抽出物のいずれか1種類以上を有効成分として含有するOPH活性増強剤である。「OPH活性増強剤」とは、酸化蛋白質の分解酵素であるOPHの酸化蛋白質分解活性(以下、単にOPH活性)を増強させる剤を意味する。   The OPH activity enhancer according to this example is an OPH activity enhancer containing any one or more of Yukinoshita, Ume, Toki, Kawaraketsumei, Unshimikan, Mandarin Orange, Hiramemon, Tachibana, Togeshiba, Lacanca as active ingredients. It is an agent. The “OPH activity enhancer” means an agent that enhances the oxidized proteolytic activity (hereinafter simply referred to as OPH activity) of OPH, which is an enzyme that degrades oxidized protein.

本実施形態における植物の抽出物は、植物のどの部位から抽出したものであってもよく、例えば、全草、花、種子、果実、果皮、枝、茎、葉、樹皮、根などから抽出したものであってよい。また、抽出物の性状を限定するものではない。以下に、本実施形態における各植物について説明する。   The plant extract in this embodiment may be extracted from any part of the plant, for example, extracted from whole grass, flowers, seeds, fruits, pericarp, branches, stems, leaves, bark, roots, etc. It may be a thing. Moreover, the property of the extract is not limited. Below, each plant in this embodiment is demonstrated.

また、抽出の方法は特段限定されず、溶媒抽出、蒸留、圧搾などの既知の方法を採用することができる。溶媒についても水や湯の他、エタノール、メタノール、ブチレングリコールなどを用いることができる。   Moreover, the extraction method is not particularly limited, and known methods such as solvent extraction, distillation, and pressing can be employed. As the solvent, ethanol, methanol, butylene glycol, etc. can be used in addition to water and hot water.

「ユキノシタ(Saxifraga stolonifera)」は、ユキノシタ科ユキノシタ属の植物である。ユキノシタの抽出物は、全草、花、種子、果実、果皮、枝、茎、葉、樹皮、根のいずれから抽出したものでよい。   “Saxifraga stolonifera” is a plant belonging to the genus Yukinoshita. The extract of Yukinoshita may be extracted from whole grass, flowers, seeds, fruits, fruit skin, branches, stems, leaves, bark, and roots.

「ウメ(Prunus mume)」は、バラ科サクラ属の植物である。ウメの抽出物は、全草、花、種子、果実、果皮、枝、茎、葉、樹皮、根のいずれから抽出したものでよい。   “Prunus mume” is a plant of the genus Rosaceae. The extract of ume may be extracted from any of whole grass, flowers, seeds, fruits, peels, branches, stems, leaves, bark, and roots.

「トウキ(Angelica acutiloba)」は、セリ科シシウド属の植物である。トウキの抽出物は、全草、花、種子、果実、果皮、枝、茎、葉、樹皮、根のいずれから抽出したものでよい。   “Angelica acutiloba” is a plant belonging to the genus Cericaceae. The extract of Toki may be extracted from whole grass, flowers, seeds, fruits, peels, branches, stems, leaves, bark, and roots.

「カワラケツメイ(Chamaecrista nomame)」は、マメ科カワラケツメイ属の植物である。カワラケツメイの抽出物は、全草、花、種子、果実、果皮、枝、茎、葉、樹皮、根のいずれから抽出したものでよいが、好ましくは茎と葉からの抽出物である。なお、カワラケツメイ茶はハマ茶とも称されている。   “Chamaecrista nome” is a plant belonging to the genus Kawaraketsumei. The extract of Kawaroketsumei may be extracted from whole grass, flowers, seeds, fruits, fruit skin, branches, stems, leaves, bark, and roots, but is preferably an extract from stems and leaves. Kawaraketsumei tea is also called Hama tea.

「ウンシュウミカン(Citrus unshiu Markovich)」は、ミカン科ミカン属の植物である。ウンシュウミカンの抽出物は、全草、花、種子、果実、果皮、枝、茎、葉、樹皮、根のいずれから抽出したものでよい。   “Citrus unshiu Markovich” is a plant belonging to the genus Citrus mandarin. The extract of Satsuma mandarin may be extracted from whole grass, flowers, seeds, fruits, fruit skin, branches, stems, leaves, bark, and roots.

「マンダリンオレンジ(Citrus reticulata)」は、ミカン科ミカン属の植物である。マンダリンオレンジの抽出物は、全草、花、種子、果実、果皮、枝、茎、葉、樹皮、根のいずれから抽出したものでよい。   “Mandarin orange” is a plant belonging to the genus Citrus mandarin. The mandarin orange extract may be extracted from any of whole grass, flowers, seeds, fruits, pericarp, branches, stems, leaves, bark, and roots.

「ヒラミレモン(Citrus depressa)」は、ミカン科ミカン属の植物であり「シークヮーサー」の名で知られている。ヒラミレモンの抽出物は、全草、花、種子、果実、果皮、枝、茎、葉、樹皮、根のいずれから抽出したものでよい。   “Cirrus depressa” is a plant belonging to the genus Citrus mandarin and is known by the name of “shikwasa”. The extract of hirami lemon may be extracted from whole grass, flowers, seeds, fruits, pericarp, branches, stems, leaves, bark, and roots.

「タチバナ(Citrus tachibana)」は、ミカン科ミカン属の植物である。タチバナの抽出物は、全草、花、種子、果実、果皮、枝、茎、葉、樹皮、根のいずれから抽出したものでよい。   "Citrus tachibana" is a plant of the genus Citrus mandarin. The extract of Tachibana may be extracted from any of whole grass, flowers, seeds, fruits, peels, branches, stems, leaves, bark, and roots.

「トウゲシバ(Huperzia serrata)」は、ヒカゲノカズラ科ヒカゲノカズラ属の植物である。トウゲシバの抽出物は、全草、花、種子、果実、果皮、枝、茎、葉、樹皮、根のいずれから抽出したものでよい。   “Huperzia serrata” is a plant of the genus Higangenokazura. The extract of Syringa may be extracted from whole grass, flowers, seeds, fruits, fruit skin, branches, stems, leaves, bark, and roots.

「ラカンカ(Siraitia grosvenorii)」は、ウリ科ラカンカ属の植物である。ラカンカの抽出物は、全草、花、種子、果実、果皮、枝、茎、葉、樹皮、根のいずれから抽出したものでよい。   “Shiraitia grosvenorii” is a plant of the genus Lacanca. The extract of Lacanca may be extracted from whole grass, flowers, seeds, fruits, peels, branches, stems, leaves, bark, and roots.

本実施例におけるOPH活性増強剤は、さらに既知の方法を用いることにより、当該OPH活性増強剤を含有する食品、食品添加物、医薬品、医薬部外品、化粧品などとして提供することが可能である。   The OPH activity enhancer in this example can be provided as a food, food additive, pharmaceutical, quasi-drug, cosmetic or the like containing the OPH activity enhancer by using a known method. .

例えば、医薬品とする場合には、本実施例のOPH活性増強剤を粉体や粒体としカプセルに充填したり、あるいは、賦形剤、結合剤、崩壊剤などを添加して打錠機等を用いて製造することができる。また、食品とする場合には、各植物を適宜乾燥や破砕をし、湯で煮出すことで提供できる。また、医薬品のようにカプセルや錠剤のような形態に整形して食品として提供してもよいし、他の飲料、調味料、菓子等の各種の食品にOPH活性増強剤を添加した態様で提供することもできる。   For example, in the case of a pharmaceutical product, the OPH activity enhancer of this example is filled with powder or granules, filled in a capsule, or added with an excipient, a binder, a disintegrant, etc. Can be used. Moreover, when setting it as a foodstuff, it can provide by drying or crushing each plant suitably and boiling out with hot water. Moreover, it may be provided as a food after being shaped into a capsule or a tablet like a pharmaceutical, or provided in a form in which an OPH activity enhancer is added to various foods such as other beverages, seasonings, and confectionery. You can also

また、美容液、クリーム、ローションなどの化粧品とすることもできる。例えば、美容液とする場合には、本実施例のOPH活性増強剤の他、水、コメヌカ油、ペンチレングリコール、グリセリン、スクワラン、パルミチン酸セチル、ダイマージリノール酸などを主成分とし、ヒアルロン酸Na、水添ナタネ油アルコール、カルボマー、キサンタンガム、水酸化カリウム、ジメチコン、ポリソルベート−60、ステアリン酸グリセリル、水添ヒマシ油、フェノキシエタノール、尿素、アルギニン、アルブチン、クエン酸などを添加剤とする。そして、各成分を水溶性原料・油溶性原料に分けて溶解してから、それらを加熱して混合・乳化する。これを冷却しながらエキスなどの添加物を配合し、さらに低温になったところで精油や香料などの揮発性の高いものを添加する。その後、所定の安全性の検査(菌、pH、温度安定性、粘度等)を行い、瓶などに充填して製品として提供することができる。
<試験>
Moreover, it can also be set as cosmetics, such as a cosmetic liquid, cream, and lotion. For example, when it is used as a cosmetic liquid, in addition to the OPH activity enhancer of this example, water, rice bran oil, pentylene glycol, glycerin, squalane, cetyl palmitate, dimer dilinoleic acid and the like as main components, hyaluronic acid Additives include Na, hydrogenated rapeseed oil alcohol, carbomer, xanthan gum, potassium hydroxide, dimethicone, polysorbate-60, glyceryl stearate, hydrogenated castor oil, phenoxyethanol, urea, arginine, arbutin and citric acid. Then, after each component is dissolved in a water-soluble raw material and an oil-soluble raw material, they are heated and mixed and emulsified. While cooling this, an additive such as an extract is blended, and a highly volatile substance such as essential oil or fragrance is added when the temperature becomes lower. Thereafter, a predetermined safety test (bacteria, pH, temperature stability, viscosity, etc.) is performed, and the product can be provided as a product after being filled into a bottle.
<Test>

本試験において、上記各植物の抽出物のOPH活性の増強作用について測定する。本測定ではOPHとその反応基質であるN−acetyl−L−alanine p−nitro−anilide(AAPA)との反応系に試料溶液を添加し、OPHの酵素反応への影響を評価した。   In this test, the effect of enhancing the OPH activity of each plant extract is measured. In this measurement, a sample solution was added to the reaction system of OPH and its reaction substrate, N-acetyl-L-alanine p-nitro-anilide (AAPA), and the influence of OPH on the enzyme reaction was evaluated.

本試験における各植物抽出物の試料として、化粧品、医薬部外品、食品添加物などの原料として市販されている抽出物を用いた。具体的には、ユキノシタ、ウメ、トウキ、ウンシュウミカン、マンダリンオレンジ、ヒラミレモン、タチバナ、トウゲシバ、ラカンカについては濃縮した抽出液として市販されている原料を試料とした。なお、トウゲシバは製造元が異なる2種類の試料(トウゲシバA、トウゲシバB)を用いた。また、カワラケツメイについては食品原料として市販されているカワラケツメイ全草を破砕し粉状とした原料を2g秤量し、40mlの熱水(80℃)で1時間抽出し、常温まで冷ましてから市販のお茶パックで濾して上清を回収して、他の試料と同様に液状の試料とした。また、すべての試料について、原液、10倍希釈、100倍希釈のそれぞれで測定を行った。
<測定方法>
As a sample of each plant extract in this test, an extract commercially available as a raw material for cosmetics, quasi drugs, food additives and the like was used. Specifically, as for the samples of Yukinoshita, Ume, Toki, Unshimikan, Mandarin orange, hirami lemon, Tachibana, Togeshiba, and Lacanca, raw materials marketed as concentrated extracts were used as samples. In addition, two types of samples (Togeshiba A and Togeshiba B) with different manufacturers were used as the spinach. In addition, for Kawaraketsumei, 2 g of a raw material obtained by pulverizing whole powdered Kawarakemei which is commercially available as a food material, weighed and extracted with 40 ml of hot water (80 ° C.) for 1 hour, cooled to room temperature, and then commercially available tea. The supernatant was recovered by filtration through a pack, and a liquid sample was obtained in the same manner as other samples. Moreover, about all the samples, it measured by each of undiluted | stock solution, 10 time dilution, and 100 time dilution.
<Measurement method>

OPHとしてacylamino−acid releasing enzyme(AARE)(タカラバイオ社)を、50mmol/L リン酸緩衝液(pH7.2)にて0.025U/mLに調製した。また、反応基質としてAAPA溶液(BACHEM社)を、50%エタノール液で25mmol/Lに調製した。また、反応緩衝液として、120mmol/L Tris−HCl(pH7.4)を用いた。また、ポジティブコントロールとして1mg/mLのルブソシド、ネガティブコントロールとして1mg/mLのEGCg(エピガロカテキンガレート)を用いた。   Acylamino-acid releasing enzyme (AARE) (Takara Bio Inc.) was prepared as OPH to 0.025 U / mL with 50 mmol / L phosphate buffer (pH 7.2). In addition, an AAPA solution (BACHEM) was prepared as a reaction substrate to 25 mmol / L with a 50% ethanol solution. Further, 120 mmol / L Tris-HCl (pH 7.4) was used as a reaction buffer. Further, 1 mg / mL rubusoside was used as a positive control, and 1 mg / mL EGCg (epigallocatechin gallate) was used as a negative control.

そして、マイクロプレート1ウェルに、試料10uL、0.025U/mL OPH 10uL、反応緩衝液210uLを入れて、37℃で60分間予備加温(プレインキュベーション)した。一旦、室温に戻してから、25mmol/L AAPA溶液(基質液)20uLを加え、よく混合してOPH反応を開始した。反応は37℃の恒温槽で行った。   Then, 10 uL of sample, 10 uL of 0.025 U / mL OPH, and 210 uL of reaction buffer were added to one well of the microplate, and pre-warmed (preincubation) for 60 minutes at 37 ° C. Once returned to room temperature, 20 uL of 25 mmol / L AAPA solution (substrate solution) was added and mixed well to initiate OPH reaction. The reaction was carried out in a constant temperature bath at 37 ° C.

30分、あるいは60分間隔でマイクロプレートを恒温槽から取り出し、マイクロプレートリーダーにて405nmの吸光度を測定し、OPH反応によって生じるpNA(パラニトロアニリン)を測定した。   The microplate was taken out from the thermostatic chamber at intervals of 30 minutes or 60 minutes, the absorbance at 405 nm was measured with a microplate reader, and pNA (paranitroaniline) generated by the OPH reaction was measured.

そして、OPHの活性の増強作用は、1時間当たりの吸光度変化量(反応速度)を求めるとともに、reference(Ref)として試料無添加時の反応速度を求め、下式に従ってRefの反応速度を100%とした時の活性増強作用を算出した。
(式)OPH活性増強作用(%)=(試料のOPH反応速度/RefのOPH反応速度)×100
<測定結果>
The activity of enhancing the activity of OPH is to determine the amount of change in absorbance per hour (reaction rate) and to determine the reaction rate when no sample is added as reference (Ref). The activity enhancing action was calculated.
(Expression) OPH activity enhancing action (%) = (OPH reaction rate of sample / OPH reaction rate of Ref) × 100
<Measurement results>

図1は、各試料のOPH活性増強作用を示す表である。表に示すように、本実施形態に係る、ユキノシタ、ウメ、トウキ、ウンシュウミカン、マンダリンオレンジ、ヒラミレモン、タチバナ、カワラケツメイ、トウゲシバ、ラカンカの抽出物はいずれもOPH活性増強作用を有することが分かった。
<効果>
FIG. 1 is a table showing the OPH activity enhancing action of each sample. As shown in the table, it has been found that all the extracts of Yukinoshita, Ume, Touki, Unshimikan, Mandarin orange, Hiramemon, Tachibana, Kawaraketsumei, Togeshiba, and Lacanca according to the present embodiment have an OPH activity enhancing action.
<Effect>

試験の結果として示すように、本実施形態により、ユキノシタ、ウメ、トウキ、カワラケツメイ、ウンシュウミカン、マンダリンオレンジ、ヒラミレモン、タチバナ、トウゲシバ、ラカンカのいずれか一種類以上を有効成分として含有するOPH活性増強剤などを提供することができる。   As shown as a result of the test, according to the present embodiment, an OPH activity enhancer containing any one or more of Yukinoshita, Ume, Toki, Kawaraketsumei, Unshimikan, Mandarin Orange, Hiramemon, Tachibana, Togeshiba, Lacanca as an active ingredient Etc. can be provided.

Claims (6)

ユキノシタ、ウメ、トウキ、カワラケツメイ、ウンシュウミカン、マンダリンオレンジ、ヒラミレモン、タチバナ、トウゲシバ、ラカンカの抽出物のいずれか1種類以上を有効成分として含有するOPH活性増強剤。   An OPH activity enhancer containing as an active ingredient any one or more of an extract of Yukinoshita, Ume, Touki, Kawaraketsumei, Unshimikan, Mandarin Orange, Hiramemon, Tachibana, Togeshiba, and Lacanca. 請求項1に記載のOPH活性増強剤を含有することを特徴とする、OPH活性増強用食品。   A food for enhancing OPH activity, comprising the OPH activity enhancer according to claim 1. 請求項1に記載のOPH活性増強剤を含有することを特徴とする、OPH活性増強用食品添加物。   A food additive for enhancing OPH activity, comprising the OPH activity enhancer according to claim 1. 請求項1に記載のOPH活性増強剤を含有することを特徴とする、OPH活性増強用医薬品。   A pharmaceutical product for enhancing OPH activity, comprising the OPH activity enhancer according to claim 1. 請求項1に記載のOPH活性増強剤を含有することを特徴とする、OPH活性増強用医薬部外品。   A quasi-drug for enhancing OPH activity, comprising the OPH activity enhancer according to claim 1. 請求項1に記載のOPH活性増強剤を含有することを特徴とする、OPH活性増強用化粧品。   A cosmetic for enhancing OPH activity, comprising the OPH activity enhancer according to claim 1.
JP2019029691A 2018-04-27 2019-02-21 OPH activity enhancer Pending JP2019193620A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023016664A JP2023052956A (en) 2018-04-27 2023-02-07 OPH activity enhancer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018086269 2018-04-27
JP2018086269 2018-04-27

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023016664A Division JP2023052956A (en) 2018-04-27 2023-02-07 OPH activity enhancer

Publications (1)

Publication Number Publication Date
JP2019193620A true JP2019193620A (en) 2019-11-07

Family

ID=68468933

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019029691A Pending JP2019193620A (en) 2018-04-27 2019-02-21 OPH activity enhancer
JP2023016664A Pending JP2023052956A (en) 2018-04-27 2023-02-07 OPH activity enhancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023016664A Pending JP2023052956A (en) 2018-04-27 2023-02-07 OPH activity enhancer

Country Status (1)

Country Link
JP (2) JP2019193620A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001131051A (en) * 1999-11-09 2001-05-15 Pola Chem Ind Inc AGED SKIN-PROPHYLACTIC/IMPROVING COSMETIC HAVING AGEs- DECOMPOSING ACTION
JP2017190310A (en) * 2016-04-14 2017-10-19 株式会社セプテム総研 OPH activity enhancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001131051A (en) * 1999-11-09 2001-05-15 Pola Chem Ind Inc AGED SKIN-PROPHYLACTIC/IMPROVING COSMETIC HAVING AGEs- DECOMPOSING ACTION
JP2017190310A (en) * 2016-04-14 2017-10-19 株式会社セプテム総研 OPH activity enhancer

Also Published As

Publication number Publication date
JP2023052956A (en) 2023-04-12

Similar Documents

Publication Publication Date Title
US10537516B2 (en) Composition for treating skin pigmentation and related methods
JP2014076957A (en) Desaccharification agent and skin external preparation
Silva et al. Orange thyme: Phytochemical profiling, in vitro bioactivities of extracts and potential health benefits
KR101352823B1 (en) A method for preparing functional of extract morinda citrifolia, noni and the composition comprising the same having potent skin-protecting activity and showing potent treating or preventing skin aging
JP6735225B2 (en) External skin composition and oral composition
JP2015221790A (en) External or internal preparation for skin containing extract of beta vulgaris rubra cultivated under irradiation with light having specific wavelength band
WO2012014901A1 (en) Carbonylation inhibitor
JP2015178489A (en) A skin external preparation or an internal preparation containing an extract of fenugreek cultivated by irradiation with light having a specific wavelength range.
JP7464960B2 (en) OPH activity enhancer
JP2016138148A (en) External preparation for skin
KR101793104B1 (en) Cosmetic composition for whitening skin comprising mixed extract of Cudrania tricuspidata leaf and Morus alba leaf as effective component
JP2019193620A (en) OPH activity enhancer
KR101718190B1 (en) Composition for protecting or curing human keratinocyte against UVB containing Extract of Carpomitra costata Stackhouse Batters as an active ingredient
JP2010222273A (en) Hair nourishing composition
JP2015199714A (en) External and internal preparation for skin which contain anthriscus cerefolium irradiated with light having specific wavelength band to cultivate
CN105310923B (en) The manufacturing method of Australia La Woer chrysanthemum young shoot extract of cosmetic composition and tissue cultures
JP6595195B2 (en) Skin external preparation or internal preparation containing an extract of chicory cultivated by irradiation with light having a specific wavelength range
JP2019187354A (en) OPH activity enhancer
JPH11147832A (en) Neutrophil esterase inhibitor
JP2019187355A (en) OPH activity enhancer
KR101230588B1 (en) Cosmetic composition containing natural vitamin and plant complex extract
JP2015096498A (en) AGEs decomposer
JP2020130143A (en) Oph activity enhancing agent
Writer et al. Safety Assessment of Nelumbo nucifera-Derived Ingredients as Used in Cosmetics
KR20150010530A (en) A cosmetic composition comprising critical extracts of pear

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20210413

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220217

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20221214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221220

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230613